Commission Implementing Regulation (EU) 2020/2002Dangos y teitl llawn

ANNEX VII INFORMATION REQUIRED FOR THE SUBMISSION OF ERADICATION PROGRAMMES IN ACCORDANCE WITH ARTICLE 10

SECTION 1 Submission of eradication programmes for category B and C diseases of terrestrial animals based on granting disease-free status at the level of establishments

Information to be included in eradication programmes for category B and C diseases of terrestrial animals based on granting of the disease-free status at the level of establishments:

1.

Date of submission.

2.

Name of the country.

3.

Name of disease.

4.

Territorial scope with a description and demarcation of the geographical and administrative areas covered by the eradication programme and the names of the zones and regions, if more than one region is included in the territorial scope of the programme.

5.

A description of the epidemiological situation for each zone or region, if more than one region is included in the territorial scope of the programme:

(a)

the number of establishments keeping animals of the targeted animal population by health status(1) excluding establishments falling under the derogation referred to in point (6)(f) at 31 December;

(b)

the number of animals of the targeted animal population kept in the establishments referred to in point (a) by health status;

(c)

maps indicating the density of the targeted animal population referred to in point (b) by health status;

(d)

timeline with prevalence, incidence data and, where relevant, vaccination history covering at least the past 5 years; and

(e)

information as regards the epidemiological situation in additional animal populations, where relevant.

6.

A description of the disease control strategy of the eradication programme in accordance with Article 16 of Commission Delegated Regulation (EU) 2020/689 including at least:

(a)

the sampling schemes and diagnostic methods to be used in accordance with Annex IV to Delegated Regulation (EU) 2020/689:

(i)

for the granting of the disease-free status to establishments and the maintenance of that status;

(ii)

to confirm or rule out the disease in the event of a suspected case;

(b)

the disease control measures to be applied in the event of a confirmed case;

(c)

the biosecurity and risk mitigating measures to be implemented;

(d)

type of vaccine(s) to be used and the vaccination scheme, if relevant;

(e)

the measures to be implemented as regards additional animal populations, if relevant;

(f)

the derogations to be applied in accordance with Article 19 of Delegated Regulation (EU) 2020/689, if relevant;

(g)

coordinated measures with other Member States or third countries, if relevant.

7.

A description of the organisation, supervision and roles of the parties involved in the eradication programme including at least:

(a)

the authorities in charge of coordinating and supervising the implementation of the programme;

(b)

responsibilities of all stakeholders involved.

8.

The estimated duration of the eradication programme.

9.

The intermediate targets of the eradication programme including at least:

(a)

the expected annual decrease of the number of infected establishments;

(b)

the expected annual increase of the number of disease-free establishments;

(c)

the expected vaccination coverage, where relevant.

SECTION 2 Submission of eradication programmes for infection with RABV

Information to be included in eradication programmes for infection with RABV:

1.

Date of submission.

2.

Name of the country.

3.

Territorial scope with a description and demarcation of the geographical and administrative areas covered by the eradication programme and names of zones and regions, if more than one region is included in the territorial scope of the programme.

4.

A description of the epidemiological situation during at least the past 5 years, including:

(a)

number of confirmed cases by listed animal species;

(b)

maps indicating the distribution of confirmed cases referred to in point (a) per year;

(c)

disease control strategy and results of control measures.

5.

A description of the disease control strategy of the eradication programme in accordance with Article 32 of Commission Delegated Regulation (EU) 2020/689:

(a)

surveillance, including at least:

(i)

targeted animal population;

(ii)

sampling schemes and details on the collection of dead animals;

(iii)

diagnostic methods;

(b)

if relevant, vaccination, including at least:

(i)

vaccination of kept animals in the framework of the eradication programme;

• type of vaccine(s) to be used,

• targeted population;

(ii)

vaccination of wild animals:

• definition/demarcation of the vaccination area,

• frequency and expected dates of the vaccination campaigns,

• vaccine bait(s) to be used;

• vaccine bait distribution method and designed vaccine bait density;

• description of the methods to be used to assess the correct vaccine bait distribution,

• description of the strategy to monitor the effectiveness of the vaccination as regards serology and vaccine bait uptake in the targeted animal population, the sampling schemes, with details on the collection of dead animals, and diagnostic methods,

• description of the measures to ensure the maintenance of the quality of the vaccine bait before it is distributed particularly as regards titration of the vaccine baits and controls of the cold chain,

• vaccination of stray dogs with the type of vaccine(s) to be used and the targeted population;

(c)

the disease control measures to be applied in the event of a confirmed case;

(d)

the public information campaigns to be implemented;

(e)

the measures to be implemented to reduce the contact with infected animals;

(f)

the coordinated measures with other Member States or third countries, where relevant.

6.

A description of the organisation, supervision and roles of the parties involved in the eradication programme including at least:

(a)

the authorities in charge of coordinating and supervising the implementation of the programme;

(b)

responsibilities of all stakeholders involved.

7.

The estimated duration of the eradication programme.

8.

The intermediate targets of the eradication programme including at least:

(a)

the expected annual decrease of the number of outbreaks;

(b)

the expected number of confirmed outbreaks in areas with outbreaks during the previous year;

(c)

the expected percentage of sero-conversion in targeted animal populations;

(d)

the expected percentage of vaccine uptake in animals of the targeted species.

SECTION 3 Submission of eradication programmes for infection with BTV

Information to be included in eradication programmes for infection with BTV:

1.

Date of submission.

2.

Name of the country.

3.

Territorial scope with a description and demarcation of the geographical and administrative areas covered by the eradication programme and the names of the zones and regions, if more than one region is included in the territorial scope of the programme: and the reasons for applying the derogation provided for in Article 37(3) of Delegated Regulation (EU) 2020/689, where relevant.

4.

A description of the epidemiological situation for each zone or region, if more than one region is included in the territorial scope of the programme:

(a)

the number of establishments keeping animals of the targeted animal population at 31 December;

(b)

the number of animals of the targeted animal population kept in the establishments referred to in point (a);

(c)

maps indicating:

(i)

the density of the targeted animal population referred to in point (b); and

(ii)

the geographical distribution of cases of infection with BTV by serotypes covering at least the past 5 years;

(d)

timeline with prevalence, incidence data and, where relevant, vaccination history covering at least the past 5 years;

(e)

results of vector surveillance covering at least the past 5 years;

(f)

information as regards the epidemiological situation in additional animal populations, where relevant.

5.

A description of the disease control strategy of the eradication programme in accordance with Article 37 of Delegated Regulation (EU) 2020/689 including at least:

(a)

details of the active surveillance to be implemented in accordance with Section 4 of Chapter 1 of Part II of Annex V to Delegated Regulation (EU) 2020/689 with:

(i)

maps indicating the geographical units;

(ii)

choice of sampling sites, sampling schemes and diagnostic methods used for the monitoring of sentinel animals;

(iii)

choice of sampling sites, sampling schemes and diagnostic methods used for the structured prevalence surveys;

(b)

type of vaccine(s) to be used and vaccination schemes for vaccination of the relevant targeted animal population, where relevant;

(c)

procedure and diagnostic methods to confirm or rule out the disease in the event of a suspected case;

(d)

the disease control measures to be applied in the event of a confirmed case;

(e)

movement restrictions implemented for movements of kept animals and germinal products;

(f)

the biosecurity and risk mitigating measures to be implemented;

(g)

details on vector surveillance and, where relevant, the establishment of seasonally BTV-free areas;

(h)

details on the granting to establishments of the status ‘vector protected establishment’, where relevant;

(i)

coordinated measures with other Member States or third countries, where relevant.

6.

A description of the organisation, supervision and roles of the parties involved in the eradication programme including at least:

(a)

the authorities in charge of coordinating and supervising the implementation of the programme;

(b)

responsibilities of all stakeholders involved.

7.

The estimated duration of the eradication programme.

8.

The intermediate targets of the eradication programme including at least:

(a)

the expected annual decrease of the number of confirmed cases in the targeted animal population;

(b)

the expected annual increase of the number of disease-free geographical units;

(c)

the expected vaccination coverage, where relevant.

SECTION 4 Submission of eradication programmes for category B and C diseases of aquatic animals

Information to be included in eradication programmes for category B and C diseases of aquatic animals:

1.

Date of submission.

2.

Name of the country.

3.

Name of disease.

4.

Territorial scope with a description and demarcation of the geographical and administrative areas covered by the eradication programme and the names of the zones or compartments.

5.

A description of the epidemiological situation for each zone, compartment or region if more than one region is included in the territorial scope of the programme:

(a)

the number of approved aquaculture establishments and the number of registered aquaculture establishments keeping animals of the targeted animal population, by type of production and by health status(2) at 31 December;

(b)

listed species kept in the aquaculture establishments referred to in point (a) by health status;

(c)

maps indicating:

(i)

the geographical location of the aquaculture establishments referred to in point (a) and the relevant water catchment areas; and

(ii)

the geographical distribution of cases of infection with the relevant category B or C disease covering at least the past 5 years;

(d)

information as regards the epidemiological situation in wild aquatic animals, where relevant.

6.

A description of the disease control strategy of the eradication programme in accordance with Article 46 of Delegated Regulation (EU) 2020/689 including at least:

(a)

the sampling schemes and diagnostic methods to be used in accordance with Annex VI to Delegated Regulation (EU) 2020/689 for:

(i)

health visits and sampling in aquaculture establishments;

(ii)

targeted surveillance in wild populations, where relevant;

(b)

the disease control measures to be applied in the event of a confirmed case;

(c)

the biosecurity and risk mitigating measures to be implemented;

(d)

vaccination schemes, where relevant;

(e)

the measures to be implemented as regards wild aquatic animals and the number and geographical location of sampling points where relevant;

(f)

the derogations to be applied in accordance with Article 53 of Delegated Regulation (EU) 2020/689, where relevant;

(g)

coordinated measures with other Member States or third countries, where relevant.

7.

A description of the organisation, supervision and roles of the parties involved in the eradication programme including at least:

(a)

the authorities in charge of coordinating and supervising the implementation of the programme;

(b)

responsibilities of all stakeholders involved.

8.

The estimated duration of the eradication programme.

9.

The intermediate targets of, and the disease control strategies for implementing, the eradication programme including at least:

(a)

the expected annual decrease of the number of infected aquaculture establishments and where relevant, sampling points in wild populations;

(b)

the expected annual increase of the number of aquaculture establishments and, where relevant, sampling points in wild populations that tested negative;

(c)

the expected vaccination coverage, where relevant.

(1)

Disease-free, infected or unknown.

(2)

Not-infected, infected, unknown.